GSK Secures High Blood Pressure Drug in $950 Million Deal
GSK Plc agreed to buy 35Pharma Inc., a biotech with an early-stage high blood pressure drug, as the UK pharmaceutical company expands into cardiovascular medicine.
📰 Original Source
Read full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.